# Agentic AI Healthcare Applications Research

Date: 2026-07-03

## Executive Summary

Agentic AI in healthcare is moving fastest where the task is repetitive, rules-governed, and already digital: revenue cycle, prior authorization, eligibility, scheduling, intake, documentation support, and care navigation. Clinical diagnosis and autonomous treatment remain higher-risk categories because they trigger patient-safety, transparency, liability, and possible medical-device issues.

The best near-term product wedge is not a general medical agent. It is a bounded workflow agent that gathers evidence, checks rules, drafts the next action, and escalates to a human before clinical or financial commitments are made.

For a healthcare-adjacent project like PEDGA, the safest first direction remains a no-PHI or low-PHI knowledge / referral / operations assistant: cited answers, pathway clarity, referral-intake completeness checks, payer/admin evidence packets, and gap lists. Avoid unsupervised clinical advice.

## Definition Used Here

Agentic AI means a system that can pursue a goal across multiple steps by using tools, retrieving context, deciding next actions, producing artifacts, and escalating exceptions. This is different from a chatbot that only answers a single prompt.

## Application Map

| Application area | What the agent does | Evidence signal | Risk level | Product-readiness view |
|---|---|---:|---|---|
| Revenue cycle management | Works denials, underpayments, cash posting, claims follow-up, coding support, collections workflows | Strong market pull; McKinsey frames back-end RCM as a safer starting point for agentic AI | Lower to moderate | Best near-term enterprise wedge |
| Prior authorization | Collects clinical/admin evidence, checks payer rules, drafts or submits packets, tracks status | AWS and major vendors are actively describing multi-agent prior-auth workflows | Moderate | Strong if human approval and audit trail are built in |
| Eligibility / benefits verification | Checks payer eligibility, benefits, coverage constraints, missing data | Adjacent to RCM and patient access; rules-heavy workflow | Lower to moderate | Good first workflow because it is operational, not diagnostic |
| Patient intake and scheduling | Collects forms, routes appointments, handles reschedules, gathers pre-visit history | Common vendor and provider use case; patient-facing risk requires escalation | Moderate | Useful but needs consent, identity, and safe handoff |
| Care navigation | Guides patients to programs, benefits, sites of care, follow-ups, and education | Strong commercial interest; useful for fragmented care systems | Moderate | Good if scoped to navigation, not medical decision-making |
| Clinical documentation | Ambient notes, summarization, visit prep, chart review, coding suggestions | Mature adoption pattern, but output affects medical record quality | Moderate to high | Viable with clinician review |
| Clinical decision support | Synthesizes patient data, suggests options, flags risks | ONC HTI-1 creates transparency expectations for predictive decision support in certified health IT | High | Needs evidence, governance, validation, and human control |
| Diagnosis / triage | Asks questions, recommends urgency, supports differential diagnosis | Research interest is high; patient-safety and liability risks are high | High | Avoid as first product unless formally evaluated |
| Imaging / device software | Detects or predicts findings from scans or medical signals | FDA maintains an AI-enabled medical device list and premarket expectations | Very high | Treat as regulated medical-device territory |
| Population health / chronic care | Identifies risk cohorts, monitors adherence, triggers outreach | Useful for payers/providers; uses sensitive data | Moderate to high | Good with clear thresholds and human escalation |
| Medical education / internal training | Simulates cases, tutors staff, tests policy knowledge | Lower patient-safety risk if not used for care decisions | Lower | Good internal adoption path |
| Drug discovery / research operations | Literature search, protocol drafting, candidate prioritization | Agentic systems can help research workflows but have different buyer and validation model | Moderate | Separate market from provider operations |

## What Looks Most Buildable

### 1. Evidence Packet Agent

This is the strongest pattern for healthcare operations.

The agent gathers documents, source links, policy requirements, payer rules, referral criteria, and missing fields. It produces a packet that a human can approve. This works for:

- referral readiness;
- prior authorization;
- benefits verification;
- appeal packets;
- specialist pathway documentation;
- internal operating checklists.

Why it fits: it creates leverage without claiming clinical authority.

### 2. Referral / Care Pathway Navigator

The agent answers:

- who should receive this referral;
- what information is missing;
- what payer or clinic rule applies;
- what next action should staff take;
- what source supports that answer.

This matches the PEDGA memory direction: a cited local knowledge navigator is safer and more useful than a broad autonomous healthcare agent.

### 3. Revenue Cycle Workbench

The agent works queues: denials, underpayments, missing documentation, claim status, and payer follow-up. It should record every action and keep humans in charge of final submissions.

Why it fits: back-end RCM is more rule-based and less directly clinical than triage or diagnosis.

### 4. Patient Access Assistant

The agent can handle intake, scheduling, reminders, and form completion. This is useful but becomes riskier because it is patient-facing, touches identity/PHI, and can create patient-experience failures if it oversteps.

## Risk And Governance Requirements

Any healthcare agent should include:

- role-limited tools and permissions;
- audit logs of every source, decision, and action;
- human approval before clinical, financial, or patient-facing commitments;
- PHI minimization and HIPAA-aware vendor boundaries;
- hallucination checks against cited sources;
- escalation paths for uncertainty, safety, urgency, and complaints;
- model-output monitoring after deployment;
- bias and nondiscrimination review for patient-care decision support.

## Source-Based Takeaways

FDA: AI-enabled medical-device products are already an active regulatory category. The FDA list is for marketed AI-enabled devices that have met applicable premarket requirements, but FDA also warns the list is not comprehensive. If an agent produces or automates clinical device-like functions, assume regulatory review may matter.

ONC HTI-1: Certified health IT now has transparency expectations for AI and predictive algorithms that support decision-making. Clinical users need baseline information to assess fairness, appropriateness, validity, effectiveness, and safety.

WHO: Large multimodal models are expected to affect healthcare, scientific research, public health, and drug development, but the governance focus is accuracy, bias, privacy, accountability, transparency, and safe deployment.

NIST: The AI RMF is a voluntary framework for incorporating trustworthiness into design, development, use, and evaluation. It is useful as the governance backbone for agent design.

CHAI: The health AI ecosystem is moving toward harmonized assurance, reporting, and evaluation standards so end users can judge whether tools are trustworthy.

McKinsey: Agentic AI is emerging in healthcare as organizations move from content generation to action-taking workflows. Back-end revenue cycle is presented as a lower-risk place to start because it is administrative, rules-based, and has fewer patient-facing touchpoints.

Recent academic reviews: Healthcare agents are being studied for assisted diagnosis, clinical decision support, report generation, patient chatbots, system management, and medical education, but evaluation, safety, controllability, privacy, and governance remain core unresolved issues.

## Recommendation

Start with an agentic healthcare operations workflow, not a clinical advice agent.

Best first build:

1. A cited healthcare evidence-packet generator.
2. A referral / pathway knowledge navigator.
3. A prior-auth or eligibility checklist assistant.

Keep it human-in-the-loop, source-attributed, and no-PHI by default until the product has clear access controls, audit logs, and a compliance plan.

## Sources

- FDA, Artificial Intelligence-Enabled Medical Devices: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices
- FDA, Artificial Intelligence in Software as a Medical Device: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-software-medical-device
- ONC, HTI-1 Final Rule: https://healthit.gov/regulations/hti-rules/hti-1-final-rule/
- WHO, Ethics and governance of artificial intelligence for health: guidance on large multi-modal models: https://www.who.int/publications/i/item/9789240084759
- NIST, AI Risk Management Framework: https://www.nist.gov/itl/ai-risk-management-framework
- CHAI, Blueprint for Trustworthy AI: https://www.chai.org/workgroup/responsible-ai/blueprint-for-trustworthy-ai
- McKinsey, Agentic AI and the race to a touchless revenue cycle: https://www.mckinsey.com/industries/healthcare/our-insights/agentic-ai-and-the-race-to-a-touchless-revenue-cycle
- McKinsey, Generative AI in healthcare: adoption matures as agentic AI emerges: https://www.mckinsey.com/industries/healthcare/our-insights/generative-ai-in-healthcare-current-trends-and-future-outlook
- npj Artificial Intelligence, AI agent in healthcare: applications, evaluations, and future directions: https://www.nature.com/articles/s44387-026-00076-4
- AWS, Transform healthcare prior authorization with AI agents: https://aws.amazon.com/blogs/industries/transform-healthcare-prior-authorization-with-ai-agents/
